Through
1/1
The Stephenson Foundation Term Assistant Professor of Innovation and her lab members work to engineer nanoparticles as medicinal vehicles to fit directly into a single cell.
A team of researchers in the School of Engineering and Applied Sciences has devised a method to deliver mRNA into the brain using lipid nanoparticles, potentially advancing treatments for Alzheimer’s disease and seizures.
A new platform to engineer adoptive cell therapies for specific autoimmune diseases has the potential to create therapies for allergies, organ transplants, and more.
An interdisciplinary team of researchers in the School of Engineering and Applied Science, Perelman School of Medicine, and School of Arts & Sciences has developed a technique that allows for characterization of both individual carrier and cargo for clinically important molecules.
A collaborative interdisciplinary team of researchers from Penn Dental, Medicine and Penn Engineering have discovered a game-changing synergy between ferumoxytol and stannous fluoride in treating dental caries.
Kevin B. Johnson, Jina Ko, and Sheila Shanmugan awarded NIH Common Fund’s High-Risk, High-Reward Research program.
In the two years since the cross-disciplinary research partnership was founded, CiPD has introduced microrobots that clean teeth, a new understanding of bacterial physics in tooth decay, and promising futures for lipid nanoparticles in oral cancer treatment.
New research from the University of Pennsylvania offers a safer path for CAR T cell immunotherapy.
César de la Fuente and a team of Penn engineers work on creative ways to create faster and cheaper testing for COVID-19. Their latest innovation incorporates speed and cost-effectiveness with eco-friendly materials.
Penn Engineers are the first to discover fat-filled lipid droplets’ surprising capability to indent and puncture the nucleus, the organelle which contains and regulates a cell’s DNA.
Doctoral student Kelsey Swingle in the School of Engineering and Applied Science and colleagues are using mRNA molecules to treat pre-eclampsia, a common pregnancy complication.
FULL STORY →
Michael Mitchell and Ph.D. student Kelsey Swingle of the School of Engineering and Applied Science and colleagues are using mRNA molecules to treat pre-eclampsia, a common pregnancy complication.
FULL STORY →
Lorena Grundy of the School of Engineering and Applied Science says that the debate between real and fake Christmas trees isn’t as black and white as it’s being portrayed.
FULL STORY →
Kenneth R. Foster of the School of Engineering and Applied Science says studies haven’t provided clear evidence that exposure to levels of radio frequency energy below accepted limits, such as Wi-Fi, disrupts the blood-brain barrier.
FULL STORY →
Marcelo Torres of the School of Engineering and Applied Science and colleagues are synthesizing antibiotic microbes from microbiomes in the human gut.
FULL STORY →
Kenneth Foster of the School of Engineering and Applied Science says that the most reliable conclusions are always those of expert panels that conduct systematic reviews according to established procedures.
FULL STORY →